Brown Miller Wealth Management LLC Purchases Shares of 3,784 CVS Health Co. (NYSE:CVS)

Brown Miller Wealth Management LLC purchased a new stake in CVS Health Co. (NYSE:CVS - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 3,784 shares of the pharmacy operator's stock, valued at approximately $256,000.

Other large investors have also recently added to or reduced their stakes in the company. Hopwood Financial Services Inc. acquired a new stake in shares of CVS Health during the 4th quarter worth about $29,000. McIlrath & Eck LLC lifted its stake in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the last quarter. Financial Perspectives Inc lifted its stake in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares during the last quarter. Compass Planning Associates Inc acquired a new stake in shares of CVS Health during the 4th quarter worth about $37,000. Finally, Providence First Trust Co acquired a new stake in shares of CVS Health during the 4th quarter worth about $42,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Activity

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director now directly owns 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

CVS stock opened at $67.74 on Tuesday. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $72.51. The firm has a market cap of $85.69 billion, a P/E ratio of 18.51, a P/E/G ratio of 0.98 and a beta of 0.56. The company's 50-day moving average price is $65.16 and its two-hundred day moving average price is $60.21.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same period last year, the company posted $1.31 EPS. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. On average, analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were paid a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.93%. CVS Health's payout ratio is currently 63.48%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CVS. UBS Group raised their target price on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Truist Financial raised their price target on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Piper Sandler raised their price target on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research report on Friday, March 21st. Robert W. Baird raised their price target on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Finally, Royal Bank of Canada raised their price target on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Two analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.